Durable disease control after multimodal therapy and platinum-based chemotherapy rechallenge in advanced clear cell adenocarcinoma of the urethra with lymph node metastases: a case report - Top-Institutions - MDSpire

Durable disease control after multimodal therapy and platinum-based chemotherapy rechallenge in advanced clear cell adenocarcinoma of the urethra with lymph node metastases: a case report

  • By

  • Akihiro Maeda

  • Shohei Tobu

  • Shuhei Kusano

  • Maki Kawasaki

  • Hiroaki Kakinoki

  • Mitsuru Noguchi

  • June 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Rosemere Cancer Centre, Lancashire Teaching Hospitals
    Rosemere Cancer Centre, Lancashire Teaching Hospitals

    Lancashire, England

    Key Differentiators

    • Oncology

  • #2

    The Royal Marsden Hospital
    The Royal Marsden Hospital

    London, England

    Key Differentiators

    • Oncology

  • #3

    Fox Chase Cancer Center
    Fox Chase Cancer Center

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology

  • #4

    Tisch Cancer Institute
    Tisch Cancer Institute

    New York, New York

    Key Differentiators

    • Oncology

  • #5

    Icahn School of Medicine at Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai Hospital

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

Durable disease control after multimodal therapy and platinum-based chemotherapy rechallenge in advanced clear cell adenocarcinoma of the urethra with lymph node metastases: a case report

  • by Akihiro Maeda, Shohei Tobu, Shuhei Kusano, Maki Kawasaki, Hiroaki Kakinoki, Mitsuru Noguchi

  • June 22, 2026

Related Content

Editorial: Harnessing machine learning for enhanced biomedical diagnosis and early disease detection: bridging data science and healthcare

An IHC-derived TLS–CD8–macrophage immune niche score predicts major pathological response to neoadjuvant chemoimmunotherapy in resectable NSCLC

Prostatic incidental uptake on PET/CT: an updated systematic review and meta-analysis of prevalence and malignancy risk